Blount Memorial Hospital continues to receive recognition for its outstanding heart attack treatment, this time earning a Platinum Performance Achievement Award for 2018 from the American College of Cardiology (ACC).
Platinum is the highest achievement award a facility can receive from the ACC for meeting all criteria for STEMI (ST segment elevation myocardial infarction) and non-STEMI patients for eight consecutive quarters, which Blount Memorial accomplished during 2016 and 2017. Last year, the hospital also received the ACC’s Silver Performance Achievement Award for meeting the same criteria over four consecutive quarters in 2016.
Both awards were presented based on data the hospital submitted to the ACC’s ACTION National Data Registry. Highlights from Blount Memorial’s submitted data include:
- 65 eligible STEMI patients and 48 non-STEMI patients successfully treated
- Median door-to-open-vessel time for STEMI patients of 43.5 minutes, below the national median of 59 minutes and in the 90th percentile in the nation
- Median first-medical-contact-to-open-vessel time for patients of 53 minutes, below the national average of 72 minutes and in the 90th percentile in the nation
“We’re extremely proud of this recognition,” said Blount Memorial CEO Don Heinemann. “Our STEMI team saves lives, and is constantly working to improve their ability to do so. This award is an important acknowledgement of the level of care we strive to give to our cardiac patients every day,” he said.
“Outstanding care is something we continually strive to achieve,” Blount Memorial cardiologist Dr. Jane Souther said. “We don’t rest on our laurels. We’re always reevaluating our processes and collaborating as a team, which includes first responders, our emergency department, our experienced cath lab team and our knowledgeable group of cardiologists. We are very proud of our accomplishment, but more importantly, we are proud of our ability to provide excellent patient outcomes,” she added.
Blount Memorial’s STEMI team is no stranger to accolades, having previously earned the Gold Recognition Award from the American Heart Association’s Mission: Lifeline® quality improvement program in both 2016 and 2017, as well as the Silver Recognition Award in 2015 and the Bronze Recognition Award in 2013.
Each year in the United States, approximately 250,000 people experience a STEMI caused by a complete blockage of blood flow to the heart that requires timely treatment. To prevent death and preserve heart tissue, it’s critical to immediately restore blood flow as quickly as possible by opening the blocked vessel or by giving clot-busting medication. Time is critical.